The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Eli Lilly is reaping the benefits from its innovation in diabetes and obesity management, with therapies like Mounjaro and ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American ...

The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

In a report released on April 9, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Experts concerned over promotional strategies of Eli Lilly for tirzepatide: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] As Mounjaro (tirzepatide), the blockbu ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

A woman felt like she was being "ripped open by a knife" after suffering extreme reaction to single weight loss jab Mounjaro.